Monetary Management Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-500
Closed -$38.9K 331
2025
Q3
$38.9K Hold
500
0.01% 266
2025
Q2
$39.1K Hold
500
0.01% 267
2025
Q1
$36.2K Hold
500
0.01% 266
2024
Q4
$37K Hold
500
0.01% 272
2024
Q3
$33K Sell
500
-7,615
-94% -$553K 0.01% 274
2024
Q2
$750K Hold
8,115
0.2% 104
2024
Q1
$775K Buy
8,115
+625
+8% +$52.5K 0.22% 101
2023
Q4
$571K Sell
7,490
-1,300
-15% -$90.5K 0.18% 121
2023
Q3
$609K Sell
8,790
-1,200
-12% -$96.4K 0.2% 113
2023
Q2
$942K Sell
9,990
-3,300
-25% -$287K 0.29% 82
2023
Q1
$1.1M Sell
13,290
-100
-0.7% -$7.86K 0.32% 78
2022
Q4
$999K Sell
13,390
-500
-4% -$38.5K 0.31% 83
2022
Q3
$1.15M Sell
13,890
-3,800
-21% -$366K 0.38% 71
2022
Q2
$1.68M Hold
17,690
0.53% 48
2022
Q1
$2.08M Sell
17,690
-200
-1% -$22.4K 0.55% 44
2021
Q4
$2.32M Buy
17,890
+600
+3% +$70K 0.57% 46
2021
Q3
$1.96M Buy
17,290
+2,600
+18% +$297K 0.54% 46
2021
Q2
$1.52M Sell
14,690
-100
-0.7% -$9.43K 0.46% 51
2021
Q1
$1.24M Sell
14,790
-7,520
-34% -$636K 0.39% 62
2020
Q4
$2.04M Sell
22,310
-50
-0.2% -$4.15K 0.67% 40
2020
Q3
$1.78M Buy
22,360
+350
+2% +$27.3K 0.64% 48
2020
Q2
$1.52M Buy
22,010
+800
+4% +$56.9K 0.57% 49
2020
Q1
$1.33M Buy
+21,210
New +$1.53M 0.59% 48

Other funds holding EW

Monetary Management Group's EW Position: Q4 2025 in Review

Monetary Management Group sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 500 shares — an estimated $38.9K sold.

Monetary Management Group first reported a position in EW in Q1 2020 and held it in 23 quarters. The position peaked at $2.32M in Q4 2021. 1,314 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • Monetary Management Group reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • Monetary Management Group sold 500 Edwards Lifesciences shares in Q4 2025, an estimated $38.9K.
  • Monetary Management Group first reported a position in Edwards Lifesciences in Q1 2020 and held it in 23 quarters.
  • Monetary Management Group's Edwards Lifesciences position peaked at $2.32M in Q4 2021.
  • 1,314 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Monetary Management Group's 13F filing for Q4 2025, filed 11 Feb 2026.